Medical Health & Life Science Research News

Research focused on the Orexo AB (ORX) market forecast to 2021

Orexo AB (ORX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

- Advertisement -
- Membership expired -

Download Sample Pages @  www.kminsights.com/request-sample-74360 Make an Inquiry about this news  

Orexo AB (Orexo) is an emerging specialty pharmaceutical company. It focuses on the research, formulation, development, registration and commercialization of drugs.

The company's commercial product portfolio consists of Abstral, Edluar, Zubsolv, Diabact UBT and Heliprobe System and its pipeline candidates comprise OX51 for procedure-induced pain; OX27 for breakthrough cancer pain; OX-CLI for respiratory tract diseases; and OX-MPI for rheumatoid arthritis. The company uses its proprietary drug delivery technologies in the development of these products.

- Advertisement -
- Membership expired -
It also carries out the industrial-scale production of pharmaceutical products. Orexo has strategic collaborations with various pharmaceutical companies such as Meda, Kyowa Kirin, Galena Biopharma, AstraZeneca and Boehringer Ingelheim for the development and commercialization of its product portfolio.

Orexo is headquartered in Uppsala, Sweden.

Orexo AB (ORX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.

The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

Download Sample Pages @  www.kminsights.com/request-sample-74360 Make an Inquiry about this news  

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv.

its pipeline candidates comprise OX51 for procedure-induced pain; OX-CLI for respiratory tract diseases; and OX-MPI for inflammation. The company uses its proprietary drug delivery technologies in the development of these products.

It also carries out the industrial-scale production of pharmaceutical products. Orexo has strategic collaborations with various pharmaceutical companies such as Meda, Kyowa Hakko Kirin, Sentynl Therapeutics, ProStrakan, AstraZeneca and Mundipharma for the development and commercialization of its product portfolio.

Orexo is headquartered in Uppsala, Sweden.

Orexo AB Key Recent Developments

Jul 11,2017: Orexo Interim Report Q2 2017
Apr 20,2017: Orexo: Interim Report Q1 2017
Jan 26,2017: Orexo: Full Year Report 2016
Oct 20,2016: Orexo: Interim Report January-September 2016
Jul 12,2016: Orexo: Interim Report January-June 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

 

Download Sample Pages @  www.kminsights.com/request-sample-74360 Make an Inquiry about this news         

News From

Key Market InsightsKey Market Insights
Category: Market Research Publishers and RetailersCompany profile: Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns. Our online stage, KMInsights.com, offers an unmatched gathering of market examination reports, organization audits, databooks, articles, periodical distributions, databases, on-line endorser administrations, and a great deal m ...

For more information:

Make an Inquiry about this report HERE!
  • www.kminsights.com/request-sample-74360
  • tinyurl.com/ya9wwpsn